Jeet Mukherjee
Stock Analyst at BTIG
(4.80)
# 513
Out of 4,676 analysts
142
Total ratings
66.4%
Success rate
30.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jeet Mukherjee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AAPG Ascentage Pharma Group International | Maintained: Buy | $48 | $17.32 | +177.14% | 5 | Aug 21, 2026 | |
| MNPR Monopar Therapeutics | Maintained: Buy | $117 → $133 | $110.88 | +19.95% | 17 | Aug 12, 2026 | |
| IPHA Innate Pharma | Rated: Buy | $8 → $9 | $2.09 | +330.62% | 5 | Aug 12, 2026 | |
| AVBP ArriVent BioPharma | Maintained: Buy | $42 | $29.18 | +43.93% | 4 | Aug 12, 2026 | |
| BCAX Bicara Therapeutics | Reiterated: Buy | $28 → $39 | $24.39 | +59.90% | 7 | Aug 12, 2026 | |
| AARD Aardvark Therapeutics | Maintained: Hold | n/a | $5.89 | - | 10 | Aug 12, 2026 | |
| CATX Perspective Therapeutics | Maintained: Buy | $14 | $3.21 | +336.14% | 10 | Aug 11, 2026 | |
| FTH Faeth Therapeutics | Maintained: Buy | $55 | $32.10 | +71.34% | 5 | Aug 10, 2026 | |
| VSTM Verastem | Maintained: Buy | $18 | $6.82 | +163.93% | 6 | Aug 6, 2026 | |
| FHTX Foghorn Therapeutics | Maintained: Buy | $11 | $7.01 | +56.92% | 5 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $215 | $142.58 | +50.79% | 10 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $7.84 | +53.06% | 7 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $32 | $27.05 | +18.30% | 12 | Jul 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $138 → $134 | $121.50 | +10.29% | 13 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $18 | $9.03 | +99.45% | 12 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $125 | $34.36 | +263.80% | 5 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $11.71 | n/a | 1 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $91 | $21.26 | n/a | 2 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $0.7762 | n/a | 1 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $42 | $58.92 | n/a | 1 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $17.28 | n/a | 1 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $3.18 | n/a | 1 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $62 | $39.11 | n/a | 1 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.0022 | n/a | 1 | Apr 1, 2025 |
Ascentage Pharma Group International
Aug 21, 2026
Maintained: Buy
Price Target: $48
Current: $17.32
Upside: +177.14%
Monopar Therapeutics
Aug 12, 2026
Maintained: Buy
Price Target: $117 → $133
Current: $110.88
Upside: +19.95%
Innate Pharma
Aug 12, 2026
Rated: Buy
Price Target: $8 → $9
Current: $2.09
Upside: +330.62%
ArriVent BioPharma
Aug 12, 2026
Maintained: Buy
Price Target: $42
Current: $29.18
Upside: +43.93%
Bicara Therapeutics
Aug 12, 2026
Reiterated: Buy
Price Target: $28 → $39
Current: $24.39
Upside: +59.90%
Aardvark Therapeutics
Aug 12, 2026
Maintained: Hold
Price Target: n/a
Current: $5.89
Upside: -
Perspective Therapeutics
Aug 11, 2026
Maintained: Buy
Price Target: $14
Current: $3.21
Upside: +336.14%
Faeth Therapeutics
Aug 10, 2026
Maintained: Buy
Price Target: $55
Current: $32.10
Upside: +71.34%
Verastem
Aug 6, 2026
Maintained: Buy
Price Target: $18
Current: $6.82
Upside: +163.93%
Foghorn Therapeutics
Aug 6, 2026
Maintained: Buy
Price Target: $11
Current: $7.01
Upside: +56.92%
Aug 4, 2026
Maintained: Buy
Price Target: $215
Current: $142.58
Upside: +50.79%
Aug 4, 2026
Maintained: Buy
Price Target: $12
Current: $7.84
Upside: +53.06%
Jul 1, 2026
Rated: Buy
Price Target: $32
Current: $27.05
Upside: +18.30%
Jun 25, 2026
Maintained: Buy
Price Target: $138 → $134
Current: $121.50
Upside: +10.29%
May 13, 2026
Reiterated: Buy
Price Target: $16 → $18
Current: $9.03
Upside: +99.45%
May 1, 2026
Reiterated: Buy
Price Target: $125
Current: $34.36
Upside: +263.80%
May 23, 2025
Reiterated: Hold
Price Target: n/a
Current: $11.71
Upside: n/a
May 23, 2025
Maintained: Buy
Price Target: $91
Current: $21.26
Upside: n/a
May 21, 2025
Maintained: Buy
Price Target: $12
Current: $0.7762
Upside: n/a
May 13, 2025
Initiated Coverage: Buy
Price Target: $42
Current: $58.92
Upside: n/a
May 9, 2025
Maintained: Buy
Price Target: $100
Current: $17.28
Upside: n/a
May 7, 2025
Maintained: Buy
Price Target: $10
Current: $3.18
Upside: n/a
Apr 14, 2025
Maintained: Buy
Price Target: $62
Current: $39.11
Upside: n/a
Apr 1, 2025
Reiterated: Hold
Price Target: n/a
Current: $0.0022
Upside: n/a